NanoGroup S.A. Logo

NanoGroup S.A.

Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.

NNG | WAR

Overview

Corporate Details

ISIN(s):
PLNNGRP00011 (+3 more)
LEI:
259400HXWEAZUWRLY648
Country:
Poland
Address:
Warszawa Rakowiecka 36, 02-532 Warszawa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NanoGroup S.A. is a biotechnology company that develops and commercializes innovative medical solutions based on its unique, patented nanotechnology. The group's research and development work is concentrated on addressing critical medical needs, primarily in the fields of oncology and transplantology. Key projects include the development of nanoformulations for anticancer drugs, a fluid for the storage of organs intended for transplantation, nanoparticles for diagnostics and therapy, and a human blood substitute. The company operates through specialized subsidiaries, such as nanoSanguis and nanoVelos, to advance its distinct technological platforms and bring new medical technologies to market.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-08 16:18
Regulatory News Service
Oświadczenie
Polish 156.9 KB
2025-10-08 16:18
Regulatory News Service
Oświadczenie
Polish 131.2 KB
2025-10-08 16:18
Regulatory News Service
Powołanie osób nadzorujących - członków Rady Nadzorczej drugiej kadencji - Cont…
Polish 1.3 KB
2025-10-08 16:04
Regulatory News Service
Rezygnacja Członka Rady Nadzorczej - Content (PL)
Polish 508 bytes
2025-10-08 15:53
Regulatory News Service
Lista akcjonariuszy
Polish 51.0 KB
2025-10-08 15:53
Regulatory News Service
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Nadzwyczajnym…
Polish 378 bytes
2025-10-08 15:37
Regulatory News Service
Treść uchwał
Polish 127.5 KB
2025-10-08 15:37
Regulatory News Service
Treść uchwał podjętych podczas obrad Nadzwyczajnego Walnego Zgromadzenia NanoGr…
Polish 1010 bytes
2025-10-06 16:58
Board/Management Information
Oświadczenie
Polish 156.9 KB
2025-10-06 16:58
Board/Management Information
Życiorys
Polish 324.7 KB
2025-10-06 16:58
Board/Management Information
Zgłoszenie kandydata na Członka Rady Nadzorczej NANOGROUP S.A. - Content (PL)
Polish 766 bytes
2025-10-06 12:47
Board/Management Information
Oświadczenie
Polish 131.2 KB
2025-10-06 12:47
Board/Management Information
Życiorys
English 199.3 KB
2025-10-06 12:47
Board/Management Information
Zgłoszenie kandydata na Członka Rady Nadzorczej NANOGROUP S.A. - Content (PL)
Polish 780 bytes
2025-10-01 17:02
Related Party Transaction
Powiadomienie
Polish 4.4 KB

Automate Your Workflow. Get a real-time feed of all NanoGroup S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NanoGroup S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
SoftOx Solutions AS Logo
Develops non-toxic, AMR-safe antimicrobials for wound care, disinfection & airway infections.
Norway SOFTX
Solasia Pharma K.K. Logo
In-licenses and commercializes oncology treatments and supportive care products in Asia.
Japan 4597
Sopharma AD Logo
Develops, manufactures, and distributes pharmaceuticals and generics in Bulgaria and regional markets.
Bulgaria SFA
Spago Nanomedical AB Logo
Developing nanomedicines for precise cancer diagnosis and targeted radionuclide therapy.
Sweden SPAGO
Spexis AG Logo
Clinical-stage biopharma developing macrocyclic therapeutics for rare diseases and oncology.
Switzerland SPEX
Sprint Bioscience Logo
Develops & out-licenses preclinical oncology drugs for difficult-to-treat cancers.
Sweden SPRINT
STADA Arzneimittel AG Logo
A leading European manufacturer of generics, consumer healthcare, and specialty pharmaceuticals.
Germany SAZ
Stayble Therapeutics AB Logo
Develops an injectable drug for lumbar disc herniation pain as an alternative to surgery.
Sweden STABL
STCUBE Logo
Develops first-in-class immunotherapies targeting BTN1A1 for treatment-resistant cancers.
South Korea 052020
STELLA PHARMA CORPORATION Logo
Develops boron drugs for Boron Neutron Capture Therapy (BNCT), a targeted cancer radiation treatment.
Japan 4888

Talk to a Data Expert

Have a question? We'll get back to you promptly.